Skip to Content

Bioeconomy initiative

Accelerating the global transition to a bio-based economy

The time is now for biosolutions. Industries are recognizing the breakthrough potential of engineering biology techniques, which harness the power of natural biological processes to address critical planetary challenges. These innovations are essential for a healthy, prosperous, and sustainable future. They allow us to reimagine supply chains and economies globally, reshaping industries at every level. However, despite their revolutionary potential, biosolutions are rarely reaching the commercial mainstream.

As a strategic partner of the World Economic Forum, Capgemini has been co-leading the Forum’s Bioeconomy Initiative. This initiative has built a multi-stakeholder community to foster dialogue and collaboration across industries, sectors, and economies, driving forward innovation and unlocking value.

Davos 2025

In the midst of growing technological convergence, where hybrid AI meets R&D and design meets data, we believe intelligent collaboration will deliver true impact and value for all.

Latest report

Our report Accelerating the tech-driven bioeconomy, co-led with the Forum and with input from leaders from government, business, academia, research organizations, and civil society, examines how a growing embrace of biological engineering as a key commercial technology is prioritizing the planet and its inhabitants.

Related content

Subscribe to ‘Straight to the future’

Each month, delve into the latest industry insights. Don’t just keep up, stay ahead of the curve with our exclusive newsletter.

Meet our experts

synthetic biology

Richard Traherne

Head of Engineering Biology and Next Frontiers at Capgemini Invent
Richard Traherne leads Capgemini’s biotech capability and shapes new strategic business areas at Capgemini Invent by leveraging the company’s innovation expertise to create novel solutions. He has extensive experience in leadership, R&D, and international business development. His focus is on impactful innovation that drives positive change.

Dr. Cassandra Padbury

Associate Director, Technology Strategy at Cambridge Consultants, part of Capgemini Invent
Cassi identifies opportunities and realises the value of ideas. With over 20 years in R&D and deeptech consulting, she helps clients deliver impact by foreseeing change and taking advantage of technology. Working across FMCG, healthcare, energy and industrial sectors she leads projects to enable our clients to meet their strategic ambitions.

Dr. Christopher Yates

World Economic Forum Fellow on the Bioeconomy Initiative
Chris helps companies understand the emerging and disruptive technology trends and how these can be leveraged to drive transformative change for their business and industry. He has a strong focus on Industrial Biotechnology and sustainability and how to realise opportunities across the end-to-end value chain. He brings strong multi-sector experience to take a variety of clients from a vision to developing innovative technology that delivers against their strategy.